Alert: Major Price Decline (11/9/23)-Vanda Pharmaceuticals Inc (NASDAQ: VNDA).


Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock suffered a major decline of -21.9% on 11/9/23. The shares closed at $3.38. The stock has been weak relative to the market over the last nine months and has declined -22.7% during the last week.


Current PriceTarget Research Rating

With future capital returns forecasted to be in line with the cost of capital, VNDA is expected to be Value Creation neutral.

Vanda Pharmaceuticals has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Vanda Pharmaceuticals has a neutral Appreciation Score of 59 but a poor Power Rating of 15, resulting in the Negative Value Trend Rating.

Rating Review

In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.